Galvanize Therapeutics
series-c-plus
series-c-plus
Stage
1
Investors
About
Develops the Aliya® pulsed electric field (PEF) ablation system, a medical device intended to treat cancer and chronic lung disease; the company has run clinical trials evaluating the system for late-stage non-small cell lung cancer and lung metastases.
Explore Galvanize Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.